期刊文献+

宫颈癌及宫颈癌前病变3个阶梯筛查新进展 被引量:4

原文传递
导出
摘要 子宫颈癌是常见的妇科恶性肿瘤之一,由于其病因明确,加之完善的筛查手段,使宫颈癌成为可预防、可治愈的疾病。从宫颈癌前病变发展成宫颈癌,是一个较为长时间的过程,大约是10年。但是,大多数宫颈癌前病变和早期宫颈癌无症状和体征,所以筛套工作显得尤为重要,传统的3阶梯式筛查(巴氏细胞学涂片-阴道镜-组织病理学)对控制宫颈癌做出了巨大贡献。
出处 《中国妇幼保健》 CAS 北大核心 2009年第36期5247-5248,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献16

  • 1郎景和.子宫颈上皮内瘤变的诊断与治疗[J].中华妇产科杂志,2001,36(5):261-263. 被引量:1250
  • 2潘秦镜,李凌,乔友林,章文华,张询,吴令英,李爱玲,戎寿德,赵芳辉,孙耘田,JeromeL.Belinson,RobertG.Pretorius.液基细胞学筛查宫颈癌的研究[J].中华肿瘤杂志,2001,23(4):309-312. 被引量:443
  • 3乔友林,章文华,李凌,潘秦镜,杨玲,吴令英,戍寿德,李爱玲,张询,任生达,Belinson J.子宫颈癌筛查方法的横断面比较研究[J].中国医学科学院学报,2002,24(1):50-53. 被引量:351
  • 4程雪梅,陈继明,李思源.宫颈癌筛查方法的研究进展[J].中国妇幼健康研究,2007,18(2):172-175. 被引量:14
  • 5Bosch FX, Lorincz A, Munoz N et al. The causal relation between human papillomavirus and cervical cancer [ J]. J Clin Pathol, 2002, 55 (4) : 244.
  • 6Thomas DB, Qin Q, Kuypers Jet al. Human papillomaviruses and cervical cancer in Bangkok,Ⅱ : risk factors for in situ and invasive squamous cell cervical carcinomas [J] . Am J Epidemiol, 2001, 153 (1): 732.
  • 7Kuhn L, Denny L, Pollack A et al. Human papillomavirus DNA testing for cervical cancer screening in low - resouree settings [ J] . Natl Cancer Inst, 2000, 92 (2): 818.
  • 8Belinson JL, Qiao YL, Pretorius R et al. Shanxi province cervical cancer screening study, a cross - sectional comparative trial of multiple techniques to detect cervical intraepithelial neoplasa [ J] . Gynecological Oncology, 2001; 83 (2) : 439.
  • 9Monsonego J. Colposeopy: The value of HPV testing in clinical practice [J] . Gynecol Obstet Fertil, 2004, 32 (1) : 62.
  • 10魏丽惠,李克敏,耿力,吴瑞芳,赵昀,赵健,崔淑慧,乌兰娜,赵超,屠铮.子宫颈病变筛查及处理指南(草案)[J].中国妇产科临床杂志,2006,7(2):84-88. 被引量:16

二级参考文献35

  • 1卫生部肿瘤防治研究办公室.中国恶性肿瘤死亡调查研究[M].北京:人民卫生出版社,1979,1..
  • 2[1]Yang L,Parkin DM,Li LD,et al.Estimation and projection of the national profile of cancer mortality in China: 1991-2005.Br J Cancer.2004,90:2157-2166.
  • 3[2]Turek LP,Smith EM.The genetic progran of genital human papillomaviruse in infection and cancer.Obstet Gynecol Clin North Am,1996,23: 735-758.
  • 4[3]Kuhn L,Denny L,Pollack A,et al.Human papillomavirus DNA testing for cervical cancer screening in low-resouree settings.Natl Cancer Inst,2000,92:818-822.
  • 5[5]Bekkers RL,Massuger LF,Bulten J,et al.Epidemiological and clinical aspects of human papillomavirus detection in the prevention of cervical cancer.Rev Med Virol,2004.14:95-105.
  • 6[6]Jacobs MV,Walboomers JM,Snijders PJ,et al.Distribution of 37 mucosotropic HPV types in women with cytologycally normal cervical smear:The age-related patterns for high-risk and low-risk Types.Int J Cancer,2000,87:221-227.
  • 7[7]Kjaer SK,wan den Brule AJC,Bock JE,et al.Human papillolmavirus: the most significant risk determinant of cervical intraepithelial neoplasia.Int J Cancer,1996,65: 601-660.
  • 8[8]Kjaer SK.Type specific persistence of high risk human papillomavirus(HPV)as indicator of high grade cervical squamous intraepithelial lesions in young women: population based prospective follow up study.BMJ,2002,325:572-578.
  • 9[9]Green S,Walter P,Kumar V,et al.Human oestrogen receptor cDNA:sequence,expression and homology to v-erb-A.Nature,1986,320(6058):134-139.
  • 10[10]Nobbenhuis MA,Walboomers JM,Helmerhorst TJ,et al.Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.Lancet,1999;354:20-25

共引文献2008

同被引文献36

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部